Literature DB >> 22582912

Characterization of the phenotype of high collagen-producing fibroblast clones in systemic sclerosis, using a new modified limiting-dilution method.

L Zhu1, D Gao, J Yang, M Li.   

Abstract

BACKGROUND: Overproduction of type I collagen in fibroblasts of systemic sclerosis (SSc) is the hallmark of fibrosis. Establishment and characterization of the phenotype of SSc fibroblasts has been hindered by the heterogeneity between fibroblasts and the lack of adequate cloning methods. AIM: To establish and investigate the characteristics of the SSc high collagen-producing fibroblast phenotype.
METHODS: Primary cultured fibroblasts from skin biopsies of patients with SSc and normal controls were cloned by a new modified limiting-dilution method. All clones were divided into different subpopulations based on their α1(I) procollagen (COL1A1) mRNA level detected by real-time reverse transcriptase PCR assay. In the different subpopulations, cell growth and cycle distribution were analysed by MTT and flow cytometry, COL1A1 promoter activity was examined by transient transfection, and the binding activity of Sp1 to the COL1A1 proximal promoter was investigated by quantitative chromatin immunoprecipitation.
RESULTS: The clonogenicities of SSc and normal control fibroblasts were similar, but the mean COL1A1 mRNA level of clones and the percentage of the subpopulation with a high COL1A1 mRNA level were significantly higher in SSc fibroblasts than in controls. There was no significant difference on cell growth and cycle between different subpopulations of SSc and control fibroblasts. The COL1A1 proximal promoter activity and its binding activity to Sp1 in the clones were strongly correlated with their COL1A1 mRNA level.
CONCLUSION: Overproduction of collagen in an SSc fibroblast subpopulation seems to result mainly from the abnormally activated transcription of COL1A1 rather than from overproliferation of fibroblasts. The new modified limiting-dilution method provides a useful means for characterizing cells with heterogeneous phenotypes. © The Author(s). CED
© 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582912     DOI: 10.1111/j.1365-2230.2011.04254.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

1.  Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients.

Authors:  Loubna Chadli; Britt Sotthewes; Kejie Li; Stefan N Andersen; Ellen Cahir-McFarland; Marc Cheung; Patrick Cullen; Annemarie Dorjée; Jeska K de Vries-Bouwstra; Tom W J Huizinga; David F Fischer; Jeroen DeGroot; Joanne L Viney; Timothy S Zheng; Jamil Aarbiou; Agnes Gardet
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

2.  Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction.

Authors:  Xiaoqin Yang; Ji Yang; Xiaojing Xing; Linlin Wan; Ming Li
Journal:  Arthritis Res Ther       Date:  2014-01-07       Impact factor: 5.156

3.  Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis.

Authors:  Massimo Cugno; Angelo V Marzano; Maurizio Lorini; Vincenzo Carbonelli; Alberto Tedeschi
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

4.  Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.

Authors:  Mengguo Liu; Ji Yang; Xiaojing Xing; Xiangxiang Cui; Ming Li
Journal:  Arthritis Res Ther       Date:  2014-12-31       Impact factor: 5.156

5.  Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.

Authors:  Yinghua Song; Lubing Zhu; Ming Li
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

6.  Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH.

Authors:  Giuseppina Abignano; Heidi Hermes; Christopher W Wasson; Maya Malaab; Rebecca L Ross; Sergio A Jimenez; Howard Y Chang; Carol A Feghali-Bostwick; Francesco Del Galdo
Journal:  Ann Rheum Dis       Date:  2020-02-10       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.